BioAtla (BCAB) Operating Leases (2021 - 2026)

BioAtla's Operating Leases history runs 6 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• On a quarterly basis, Operating Leases changed N/A year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.8 million, changed N/A from the prior year.
• Operating Leases retreated to $4.5 million in Q1 2026 per BCAB's latest filing, from $4.8 million in the prior quarter.
• Across five years, Operating Leases topped out at $5.2 million in Q2 2025 and bottomed at $415000.0 in Q1 2024.
• The 5-year median for Operating Leases is $2.8 million (2022), against an average of $2.9 million.
• Across the five-year window, Operating Leases tumbled 38.22% in 2022 and tumbled 79.88% in 2024, its largest moves.
• Year by year, Operating Leases stood at $2.5 million in 2022, then plunged by 66.02% to $836000.0 in 2023, then slumped by 50.36% to $415000.0 in 2024, then soared by 1050.12% to $4.8 million in 2025, then decreased by 4.99% to $4.5 million in 2026.
• Per Business Quant, the three latest BCAB Operating Leases figures stand at $4.5 million (Q1 2026), $4.8 million (Q4 2025), and $5.0 million (Q3 2025).